Produkty 13900-61-3

CAS 13900-61-3 występuje w naszej ofercie pod nazwami: 3,17-Dihydroxy-16-methyl-(3Beta,16Beta)-pregn-5-en-20-one, 3,17-Dihydroxy-16-methyl-(3b,16b)-pregn-5-en-20-one. Oferty producentów: TRC. Dostępne opakowania: 100mg, 1g, 500mg.

3,17-Dihydroxy-16-methyl-(3Beta,16Beta)-pregn-5-en-20-one
TRC
  • opakowanie: 100mg, 500mg
  • Warianty: 2
Zobacz produkt
3,17-Dihydroxy-16-methyl-(3b,16b)-pregn-5-en-20-one
TRC
  • opakowanie: 1g
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

1-[(3S,8R,9S,10R,13S,14S,16S,17R)-3,17-dihydroxy-10,13,16-trimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethanone (CAS 13900-61-3) to związek chemiczny o wzorze sumarycznym C22H34O3 i masie molowej 346.5 g/mol. Nazwa systematyczna IUPAC: 1-[(3S,8R,9S,10R,13S,14S,16S,17R)-3,17-dihydroxy-10,13,16-trimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethanone. InChIKey: MDCCMZGGNCMFPQ-RGEWOSBMSA-N.

Dane identyfikacyjne
Wzór sumarycznyC22H34O3
Masa molowa346.5 g/mol
Nazwa IUPAC1-[(3S,8R,9S,10R,13S,14S,16S,17R)-3,17-dihydroxy-10,13,16-trimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethanone
InChIKeyMDCCMZGGNCMFPQ-RGEWOSBMSA-N
SMILESC[C@H]1C[C@H]2[C@@H]3CC=C4C[C@H](CC[C@@]4([C@H]3CC[C@@]2([C@]1(C(=O)C)O)C)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 3-beta,17-alpha-Dihydroxy-16-beta-methylpregn-5-en-20-one, 3,17-Dihydroxy-16-methyl-(3b,16b)-pregn-5-en-20-one, 3beta,17-Dihydroxy-16beta-methyl-pregn-5-en-20-one; Epoxypregnenolone, 3beta,17-Dihydroxy-16beta-methylpregn-5-en-20-one, 3,17-Dihydroxy-16-methylpregn-5-en-20-one
Powiązane formy tego związku
1-[(3S,8R,9S,10R,13S,14S,16R,17R)-3,17-dihydroxy-10,13,16-trimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethanone C22H34O3
Izomery (ten sam wzór sumaryczny)
[(1S,3S,5S,8S,10S)-10-hydroxy-8,12,15,15-tetramethyl-4-methylidene-5-tricyclo[9.3.1.03,8]pentadec-11-enyl] acetate C22H34O3
(1R,2R,3aS,9aS)-1-[(3S)-3-hydroxyoctyl]-5-methoxy-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-2-ol C22H34O3
(8S,9R,10S,13R,14S,17R)-9-hydroxy-17-[(2S)-1-hydroxypropan-2-yl]-10,13-dimethyl-2,6,7,8,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-one C22H34O3
1-[(3S,8S,9S,10R,13S,14S,16R,17R)-3-hydroxy-16-methoxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone C22H34O3
2-hydroxy-6-[(Z)-pentadec-8-enyl]benzoic acid C22H34O3
(7Z,10Z,14E,16Z,19Z)-13-hydroxydocosa-7,10,14,16,19-pentaenoic acid C22H34O3
(1S,2S,10R,11R,14S,16R)-2,7,7,10-tetramethyl-6,8-dioxapentacyclo[14.3.1.01,14.02,11.05,10]icosan-17-one C22H34O3
[(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] acetate C22H34O3
[(3S,8S,9S,10R,13S,14S,17S)-17-(hydroxymethyl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate C22H34O3